BridgeBio shareholders approve all proposals, including 6.5M share increase to equity plan

BridgeBio Pharma, Inc.

All five director nominees elected: Eric Aguiar, Jennifer Cook, Andrea Ellis, Fred Hassan, Ali Satvat.
Advisory say-on-pay vote passed with ~134.3M for, ~9.3M against.
Deloitte & Touche ratified as independent auditor for fiscal 2024.
2021 Stock Plan amended to increase shares reserved by 6.5 million.
Broker non-votes were 17.3M on director election and most other proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.